{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:21Z","timestamp":1788872361033,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.imlet.2013.07.010","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T14:15:28Z","timestamp":1377094528000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-\u03b12A and ribavirin therapy in patients with chronic hepatitis C"],"prefix":"10.1016","volume":"154","author":[{"given":"Ana Ruth","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana Grazziela Alves","family":"Coelho-dos-Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Patr\u00edcia Viana","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane Am\u00e1bili de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo Diniz","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Maur\u00edcio de","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a Monteiro","family":"Tarrag\u00f4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo de Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson da Fonseca","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia Luz","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin\u00e9sio","family":"Talhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Malheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2013.07.010_bib0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.imlet.2013.07.010_bib0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0020","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2013.07.010_bib0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00535-010-0322-5","article-title":"Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis","volume":"46","author":"Kurosaki","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hep.510280129","article-title":"Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C","volume":"28","author":"Nelson","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0016-5085(00)70217-4","article-title":"C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C","volume":"118","author":"Cramp","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0045","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/gast.2002.36045","article-title":"Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C","volume":"123","author":"Kamal","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0050","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/hep.20266","article-title":"Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics","volume":"39","author":"Kamal","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/medicina44070066","article-title":"Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study","volume":"44","author":"Guobuzaite","year":"2008","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.imlet.2013.07.010_bib0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/S0074-02762013000100008","article-title":"Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene","volume":"108","author":"Grandi","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.imlet.2013.07.010_bib0065","first-page":"190","article-title":"Validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: a useful pharmacogenetic tool for prediction of hepatitis C treatment response","volume":"12","author":"Sharafi","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1016\/j.imlet.2013.07.010_bib0070","doi-asserted-by":"crossref","first-page":"e8387","DOI":"10.5812\/hepatmon.8387","article-title":"Distribution of IL28B genotypes in iranian patients with chronic hepatitis c and healthy individuals","volume":"12","author":"Sharafi","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1016\/j.imlet.2013.07.010_bib0075","doi-asserted-by":"crossref","DOI":"10.1099\/vir.0.051052-0","article-title":"Favourable\u2019 IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype-3a infection and do not predict sustained virological response after 24 weeks of therapy","author":"Bucci","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2013.04.007","article-title":"Treatment optimization of and prediction of HCV clearance in patients with acute HCV infection","author":"Mangia","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0036-46652007000300008","article-title":"Primary screening of blood donors by nat testing for HCV-RNA: development of an in-house method and results","volume":"49","author":"Wendel","year":"2007","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"Pt 7","key":"10.1016\/j.imlet.2013.07.010_bib0090","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1099\/0022-1317-76-7-1749","article-title":"Variation of the hepatitis C virus 5\u2019 non-coding region: implications for secondary structure, virus detection and typing. The International HCV Col laborative St udy Gr oup","volume":"76","author":"Smith","year":"1995","journal-title":"J Gen Virol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0095","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/jmv.21521","article-title":"Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis","volume":"81","author":"Maia","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QAD.0b013e3282f1da99","article-title":"Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C","volume":"22","author":"Martin-Carbonero","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.imlet.2013.07.010_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1440-1746.2011.06802.x","article-title":"Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin","volume":"27","author":"Namikawa","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3851\/IMP1869","article-title":"Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C","volume":"16","author":"Umemura","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.imlet.2013.07.010_bib0115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1478-3231.2007.01507.x","article-title":"Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile","volume":"27","author":"Gelderblom","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.imlet.2013.07.010_bib0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2567.2010.03382.x","article-title":"PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes\/macrophages during chronic hepatitis C virus infection","volume":"132","author":"Ma","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0125","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1189\/jlb.0507268","article-title":"HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production","volume":"82","author":"Waggoner","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0130","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2013.07.010_bib0135","doi-asserted-by":"crossref","first-page":"e19664","DOI":"10.1371\/journal.pone.0019664","article-title":"Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2013.07.010_bib0140","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1128\/JVI.00409-07","article-title":"Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction","volume":"81","author":"Golden-Mason","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0145","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/infdis\/jiq165","article-title":"Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients","volume":"203","author":"Yoneda","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.imlet.2013.07.010_bib0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.meegid.2011.01.022","article-title":"Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan","volume":"11","author":"Aziz","year":"2011","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.imlet.2013.07.010_bib0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2119\/molmed.2010.00124","article-title":"Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis","volume":"17","author":"Fujita","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.imlet.2013.07.010_bib0160","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/hep.22826","article-title":"Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns","volume":"49","author":"Dai","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2013.07.010_bib0165","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/hep.22543","article-title":"Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors","volume":"48","author":"Shirakawa","year":"2008","journal-title":"Hepatology"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247813001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247813001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:33:38Z","timestamp":1759044818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247813001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0165247813001028"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2013.07.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-\u03b12A and ribavirin therapy in patients with chronic hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2013.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}